glp-1 cortisol The dual impact of receptor agonists on metabolic and reproductive health in polycystic ovary syndrome: insights from human and animal trials GIP, GLP-1, ACTH and cortisol

These pleiotropic effects, largely mediated through enhanced insulin sensitivity, anti-inflammatory pathways, and metabolic regulation, position tirzepatide as a promising agent in the integrated management of chronic metabolic diseases

Both classic Gs-Camp/Pka/Creb and alternative Gs-Camp/Pka/P38 Beta/Creb signal pathways mediate exenatide-stimulated expression of M2 microglial markers

The American Diabetes Association notes that GLP-1 receptor agonists are not preferred in patients with severe constipation, significant gastroparesis, or recurrent bowel blockage

Obesity 21 (11), 21632171

Barlowe TS, et al

Konkov, L